Quality of Care for Knee and Hip Osteoarthritis in Elderly Patients

NCT04170218 | Unknown

• 1 other identifier: APHP190201
• Study Type: observational
• Target: 405
• Locations: 1 country
• Sites: 1

Brief Summary

Introduction: Hip and knee osteoarthritis (OA) was ranked in 2010 as the eleventh highest contributor to global disability. In France in 2014, non-spinal OA was the leading self-reported cause of morbidity among adults over sixty-five years of age, with a prevalence of 49.5 per cent. OA is known to be the first cause of disability in activities of daily life and a risk factor of frailty among people over seventy-five years of age. Despite its major impact on the elderly population's quality of life and health, quality of care for OA in elderly patients remains understudied. Objective: The study aims to assess the quality of care for knee and hip OA in patients aged 75 years and over.

Conditions

Knee Osteoarthritis; Hip Osteoarthritis; Quality of Healthcare; Elderly

Keywords

knee osteoarthritis; hip osteoarthritis; quality of healthcare; elderly

Outcome Measures

Primary Outcomes (1)

• number of participants referred to an orthopedic surgeon as assessed by ACOVE's quality indicator questionnaire

  at enrollment

Secondary Outcomes (18)

• rate of eligible patients who passed the quality indicator about annual assessment of functional status and degree of pain, assessed by questionnaire

  at enrollment

• rate of eligible patients who passed the quality indicator about exercise therapy for patients with newly diagnosed knee osteoarthritis, assessed by questionnaire

  at enrollment

• rate of eligible patients who passed the quality indicator about education regarding the natural history, treatment, and self- management of osteoarthritis, assessed by questionnaire

  at enrollment

• rate of eligible patients who passed the quality indicator about acetaminophen as first-line pharmacologic therapy, assessed by questionnaire

  at enrollment

• rate of eligible patients who passed the quality indicator about advising patients treated with non-steroidal anti-inflammatory drugs (NSAIDs) of their risks, assessed by questionnaire

  at enrollment

Eligibility Criteria

• Age: 75 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients hospitalized in seven geriatric departments of three hospitals of "Assistance Publique - Hôpitaux de Paris", for any cause of admission

You may qualify if:

• patients aged seventy-five years or over
• with symptomatic hip or knee osteoarthritis according to the American College of Rheumatology criteria
• with pain for more than three months
• affiliated to French social security
• having given their oral non-opposition to participate (or oral non-opposition of the guardian in case of legal guardianship)

You may not qualify if:

• clinical or radiological sign suggesting a differential diagnosis for hip or knee pain
• acute disease with clinical repercussion on walking
• life-threatened patients

Sponsors & Collaborators

• Assistance Publique - Hôpitaux de Paris: lead

Study Sites (1)

Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR

Créteil, 94010, France

Location

MeSH Terms

Conditions

Osteoarthritis, Knee; Osteoarthritis, Hip

Condition Hierarchy (Ancestors)

Osteoarthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases

Study Officials

• Jean-Philippe David, PhD

  STUDY DIRECTOR

Central Study Contacts

Valeriane Reau

CONTACT

33776698321; reau.valeriane@gmail.com

Anissa Zarour

CONTACT

33149813344; anissa.zarour@aphp.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 25, 2019
• First Posted: November 20, 2019
• Study Start: December 1, 2019
• Primary Completion: December 1, 2021
• Study Completion: December 1, 2022
• Last Updated: November 20, 2019

Record last verified: 2019-10

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)